SARS: Revenue Generator Or Flash-In-The-Pan Illness? May 7, 2003 By Brady Huggett No Comments Biotechnology oftentimes eases into the wake of U.S. - and global - burgeoning health risks. That wake occasionally allows companies to ride the waves of newfound investor interest. (BioWorld Today)Read More
AVI Raises $15M Privately From Investors Who Acted In A Hurry May 6, 2003 By Aaron Lorenzo No Comments
Sequencing Headway On SARS Could Lead To Critical Vaccine April 16, 2003 By Randy Osborne No Comments
RSS